Psychiatr. pro Praxi, 2006; 1: 23-25

ANTIDEPRESSANTS IN THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION

prof. MUDr. Alexandra Žourková CSc
Psychiatrická klinika LF MU a FN Brno

The author describes studies of therapeutic efficaccy of antidepressants in the treatment of female sexual dysfunction. Antidepressants stimulating sexual activity (moclobemide, bupropion, trazodone) demonstrate good results in the therapy of decreased libido and female arousal disorder.

Keywords: Key words: sexual dysfunction, therapy, antidepressants.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Žourková A. ANTIDEPRESSANTS IN THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION. Psychiatr. praxi. 2006;7(1):23-25.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Clayton AH, McGarvey EL, Clavet GJ, Piazza L. Comparison of sexual functioning in clinical and nonclinical populations using the Changes in sexual functioning questionnaire (CSFQ), Psychophamacology Bulletin, 1997; 33: 731-745.
    2. Crenshaw TL, Goldberg JP, Stern WC. Pharmacologic modification of psychosexual dysfunction, J. of Sex and Marital therapy, 1987; 13: 239-252. Go to original source... Go to PubMed...
    3. Češková E, Žourková A, Skotáková S, Kašpárek T. The pitfalls of antidepressant treatment (gender differences), Psychiatrie, 2004; 8, suppl.4: 16-17.
    4. Feiger A, Kiev A, Shrivastava RK, Wisselink PG, Wilcox CS. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, an affects on sexual function and satisfaction, J. Cli. Psychiatry, 1996; 57 (suppl.2): 53-62. Go to original source...
    5. Fourcroy JL. Female sexual dysfunction, potential for pharmacotherapy, Drugs, 2003; 63: 1445-1457. Go to original source... Go to PubMed...
    6. Gartrell N. Increased libido in women receiving trazodone, Am. J. Psychiatry, 1986; 143: 781-782. Go to original source... Go to PubMed...
    7. Hawton K, Gath D, Day A. Sexual function in a community sample of middle-age women with partners: Effects of age, marital, socioeconomic, psychiatric, gynecological, and menopausal factors. Archives of Sexual Behavior, 1994; 23: 375-395. Go to original source... Go to PubMed...
    8. Hensley PP, Nurnberg HG. SSRI Sexual dysfunction: a Female Perspective, Journal of Sex and Marital Therapy, 2002; 28: 143-153. Go to original source... Go to PubMed...
    9. Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline and venlafaxine, J. Clin. Psychiatry, 2000; 61: 276-281. Go to original source... Go to PubMed...
    10. Lingjaerde O, Ahlfors VG, Dencker SJ, Elgen K. The UKU side effects rating scale for psychotropic drugs and a cross sectional study of side effects in antipsychotic patients. Acta Psychiatr. Scand. Suppl. 1987: 1-100. Go to original source... Go to PubMed...
    11. Mathew RJ, Weinman JL. Sexual dysfunction in depression, Arch. Sex. Behav., 1982; 11: 323-325. Go to original source... Go to PubMed...
    12. McGahuey CA, Delgado PL, Gelenberg AJ. Assessment of sexual dysfunction using the Arizona sexual experiences scale (ASEX) and implications for the treatment of depression. Psychiatric annals 1999; 29: 39-45. Go to original source...
    13. Mellis MR, Argiolas A. Dopamine and sexual behavior, Neurosc.Biobehav.Rev., 1995; 19: 19-38. Go to original source... Go to PubMed...
    14. Meston CM, Gorzalka BB. Psychoactive drugs and human sexual behaviour: the role of serotonergic activity, J.Psychoactive Drugs 1992; 24: 1-40. Go to original source... Go to PubMed...
    15. Meston CM, Frolich PF. The Neurobiology of Sexual Function, Arch.Gen.Psychiatry, 2000; 57: 1012-1030. Go to original source... Go to PubMed...
    16. Modell JG, May RS, Katholi CR. Effect of bupropion-SR on orgasmic dysfunction in nondepressed subjects: a pilot study, J. of Sex and Marital therapy, 2000; 26: 231-240. Go to original source... Go to PubMed...
    17. Piazza LA, Markowitz JC, Kocsis JH, Leon AC, Portera L, Miller NL, Adler D. Sexual functioning in chronically depressed patients treated with SSRI antidepressants: A pilot study, Am.J.Psychiatry, 1997; 154: 1757-1759. Go to original source... Go to PubMed...
    18. Pollack M-H, Reiter S, Hammerness P. Genitourinary and sexual adverse effects of psychotropic medication, Int.J.Psychiatry in Medicine 1992; 22: 305-327. Go to original source... Go to PubMed...
    19. Riley AJ, Riley EJ. Cholinergic and adrenergic control of human sexual responses, In: Wheatley D.(Eds.)Psychopharmacology and sexual disorders, New York, Oxford University Press Inc., 1983: 129-137.
    20. Riley AJ. Alpha adrenoreceptors and human sexual function In: Bancroft J., ed.The Pharmacology of Sexual Function and Dysfunction. Amsterdam: Elsevier Science BV 1995: 307-322.
    21. Rosen RC, Ashton AK. Empirical status of the "New Aphrodisiacs", Archives of Sexual Behavior, 1993; 22: 521-543. Go to original source... Go to PubMed...
    22. Segraves RT. Emerging therapies for female sexual dysfunction, Expert Opin. Emerging Drugs, 2003; 8: 515-522. Go to original source... Go to PubMed...
    23. Segraves RT, Balon R. Sexual pharmacology: fast facts. www Norton&Company Inc. New York, 2003.
    24. Segraves RT, Clayton A, Croft H, Wolf A, Warnock J. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women, J. of Clinical Psychopharmacology, 2004; 24: 339-341. Go to original source... Go to PubMed...
    25. Shen WW, Hsu JH. Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients. Int J. Psychiatry Med., 1995; 25: 239-248. Go to original source... Go to PubMed...
    26. Trojan O, Kollan P. Aurorix v terapii ženských sexuálních dysfunkcí, Psychiatrie, 2004; 8, suppl.1.
    27. Weiss P, Zvěřina J. Sexuální chování obyvatel ČR. Praha: Portál 2001.
    28. Wilson CA. Pharmacological targets for the control of male and female sexual behaviour In: Riley AJ, Peet M, Wilson C, eds.Sexual Pharmacology, Oxford: Oxford Medical Publications, 1993: 1-58.
    29. Žourková A, Robeš M, Havlíková P, Obrovská V. Výskyt sexuálních dysfunkcí při léčbě antidepresivy u ambulantních pacientů Psychiatrické kliniky FN v Brně, Česká a Slovenská Psychiatrie, 2004; 100: 125-133.
    30. Žourková A, Novotná J. Gender differences as to efficacy and sexual functions in the long-term trazodone treatment (preliminary results), International Journal of Psychiatry in clinical practice, přijato k publikaci 2005. Go to original source...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.